Don B. Sanders, M.D., MS
Affiliations: | 2015 | University of Wisconsin, Madison, Madison, WI | |
| 2016- | Riley Hospital for Children/ Indiana University, Indianapolis, IN, United States |
Area:
cystic fibrosisGoogle:
"Don Sanders"Parents
Sign in to add mentor| Ron Gibson | fellowship/program director | 2006-2009 | Seattle Children's Hospital |
| Greg J. Redding | division chief | 2006-2009 | Seattle Children's Hosp |
| Greg J. Redding | division chief | 2006-2009 | Seattle Children's Hosp |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sanders DB, Mayer-Hamblett N, Rosenfeld M, et al. (2024) Characteristics of individuals with cystic fibrosis in the United States ineligible for ivacaftor and elexacaftor/tezacaftor/ivacaftor. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society |
| McElvaney OJ, Heltshe SL, Odem-Davis K, et al. (2023) Adjunctive Systemic Corticosteroids for Pulmonary Exacerbations of Cystic Fibrosis. Annals of the American Thoracic Society |
| Thornton CS, Caverly LJ, Kalikin LM, et al. (2023) Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary Exacerbations. Annals of the American Thoracic Society |
| Sanders DB, Bartz TM, Zemanick ET, et al. (2023) A Pilot Randomized Trial of Pediatric Cystic Fibrosis Pulmonary Exacerbations Treatment Strategies. Annals of the American Thoracic Society |
| McElvaney OJ, Heltshe SL, Odem-Davis K, et al. (2023) Impact of lumacaftor/ivacaftor and tezacaftor/ivacaftor on treatment response in pulmonary exacerbations of F508del/F508del cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society |
| Cogen JD, Sanders DB, Slaven JE, et al. (2023) Antibiotic Regimen Changes During Cystic Fibrosis Pediatric Pulmonary Exacerbation Treatment. Annals of the American Thoracic Society |
| Heltshe SL, Russell R, VanDevanter DR, et al. (2023) Re-examining baseline lung function recovery following IV-treated pulmonary exacerbations. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society |
| Rosenfeld M, Ostrenga J, Cromwell EA, et al. (2022) Real-world Associations of US Cystic Fibrosis Newborn Screening Programs With Nutritional and Pulmonary Outcomes. Jama Pediatrics |
| Bouzek DC, Ren CL, Thompson M, et al. (2022) Evaluating FEV1 decline in diagnosis and management of pulmonary exacerbations in children with cystic fibrosis. Pediatric Pulmonology |
| Perrem L, Stanojevic S, Solomon M, et al. (2022) Evaluation of clinically relevant changes in the lung clearance index in children with cystic fibrosis and healthy controls. Thorax |